To explore the possible mechanism of deregulated GAS2 expression in T‐ALL cells, the DNA methylation content in GAS2 promoter region was analyzed, as a previous report showed that the aberrant expression of GAS2 in CML cells was associated with DNA hypomethylation [33]. The gene discussed is GAS2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.